Skip to main content
Back to feed
MarketsEmergingMediumDeveloping
4.7

Novo CEO open to direct NYSE listing, cites advantages

Novo's CEO Mike Doustdar signals openness to a direct listing on the New York Stock Exchange, citing advantages. This marks a potential shift in listing strategy for the Danish pharma giant, though no formal decision has been made. A NYSE listing could enhance US investor access and liquidity, impacting capital flows.

Dagens Industri2 days agoDK, USCredibility 26%View source

Score Breakdown

Mosaic Score4.7
Confidence0.5
Significance0.5
Source credibility0.3

Intelligence Tags

#novo#nyse#listing#pharma#capital-markets

Locations

New York

Entities

country
Source

Related signals

8 found